CIRC's Self-Developed Erythrocyte Lifespan Breath Analyzer Secures Medical Device Registration

Stock News
Yesterday

CIRC (01763) announced that its subsidiary, Anhui Yanghe Medical Equipment Co., Ltd., under Zhonghe Haidewei, has obtained a Class II medical device registration certificate for its self-developed "Erythrocyte Lifespan Determination Breath Analyzer." The approval for market launch signifies a major advancement for CIRC beyond its established expertise in Helicobacter pylori breath testing, marking its official entry into the new field of erythrocyte lifespan detection through breath analysis. This development is expected to promote the application of breath testing technology in early screening and clinical diagnosis of hematological diseases.

Clinically, erythrocyte lifespan measurement is primarily used for diagnosing anemia and hemolysis. Accelerated destruction of red blood cells can lead to hemolytic anemia, with symptoms such as fatigue, pallor, and jaundice. Measuring erythrocyte lifespan helps identify the underlying cause. It also aids in differentiating the origin of jaundice—whether due to excessive red blood cell breakdown or liver issues—in both newborns and adults, enabling quicker medical assessment. Additionally, for patients with diagnosed blood disorders, regular erythrocyte lifespan testing can evaluate treatment efficacy and monitor disease recurrence.

The analyzer operates on the principle of endogenous carbon monoxide (CO) metabolism detection. By analyzing the concentration of trace CO in exhaled breath, it scientifically calculates erythrocyte lifespan, enabling non-invasive quantitative assessment. A single test takes approximately 250 seconds to generate a report, significantly improving detection efficiency and accuracy, making it suitable for use in clinical departments such as hematology.

The device integrates testing procedures, data management, and equipment maintenance into a unified system, enhancing operational stability and user-friendliness. It meets clinical demands by simplifying operation for healthcare professionals, utilizing technological innovation to safeguard respiratory health.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10